Iain Wilkie
Stock Analyst at Morgans
(0.09)
# 4,743
Out of 5,058 analysts
158
Total ratings
27.7%
Success rate
-15.4%
Average return
Main Sectors:
Stocks Rated by Iain Wilkie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: NUZ Neurizon Therapeutics Limited | Reiterated: Buy | $0.20 | $0.08 | +153.16% | 12 | Oct 6, 2026 | |
| ASX: VFY Vitrafy Life Sciences Limited | Reiterated: Buy | $5.06 | $2.78 | +82.01% | 1 | Sep 30, 2026 | |
| ASX: EIQ Echo IQ Limited | Reiterated: Buy | $1.85 → $1.10 | $0.44 | +152.87% | 4 | Sep 9, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Downgraded: Hold | $13.00 → $10.00 | $7.55 | +32.54% | 7 | Aug 31, 2026 | |
| ASX: IME ImExHS Limited | Downgraded: Hold | $0.50 → $0.37 | $0.31 | +21.31% | 14 | Aug 31, 2026 | |
| ASX: M7T Mach7 Technologies Limited | Reiterated: Buy | $0.44 → $0.48 | $0.22 | +118.18% | 10 | Aug 31, 2026 | |
| ASX: SOM SomnoMed Limited | Reiterated: Buy | $0.75 → $0.76 | $0.23 | +230.43% | 21 | Aug 31, 2026 | |
| ASX: PME Pro Medicus Limited | Reiterated: Buy | $230.00 | $172.86 | +33.06% | 29 | Aug 19, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Reiterated: Buy | $0.12 | $0.04 | +179.07% | 10 | Jul 16, 2026 | |
| ASX: NAN Nanosonics Limited | Reiterated: Buy | $5.00 → $4.00 | $2.84 | +41.09% | 7 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.43 | $0.12 | +258.33% | 7 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.58 → $0.24 | $0.00 | n/a | 8 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.22 → $0.29 | $0.02 | n/a | 4 | Sep 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.28 → $0.78 | $0.25 | n/a | 14 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.43 | $0.09 | n/a | 3 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.31 → $1.24 | $0.32 | n/a | 4 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.89 → $1.64 | $0.01 | n/a | 3 | Feb 16, 2022 |
Neurizon Therapeutics Limited
Oct 6, 2026
Reiterated: Buy
Price Target: $0.20
Current: $0.08
Upside: +153.16%
Vitrafy Life Sciences Limited
Sep 30, 2026
Reiterated: Buy
Price Target: $5.06
Current: $2.78
Upside: +82.01%
Echo IQ Limited
Sep 9, 2026
Reiterated: Buy
Price Target: $1.85 → $1.10
Current: $0.44
Upside: +152.87%
Clinuvel Pharmaceuticals Limited
Aug 31, 2026
Downgraded: Hold
Price Target: $13.00 → $10.00
Current: $7.55
Upside: +32.54%
ImExHS Limited
Aug 31, 2026
Downgraded: Hold
Price Target: $0.50 → $0.37
Current: $0.31
Upside: +21.31%
Mach7 Technologies Limited
Aug 31, 2026
Reiterated: Buy
Price Target: $0.44 → $0.48
Current: $0.22
Upside: +118.18%
SomnoMed Limited
Aug 31, 2026
Reiterated: Buy
Price Target: $0.75 → $0.76
Current: $0.23
Upside: +230.43%
Pro Medicus Limited
Aug 19, 2026
Reiterated: Buy
Price Target: $230.00
Current: $172.86
Upside: +33.06%
Microba Life Sciences Limited
Jul 16, 2026
Reiterated: Buy
Price Target: $0.12
Current: $0.04
Upside: +179.07%
Nanosonics Limited
Feb 25, 2026
Reiterated: Buy
Price Target: $5.00 → $4.00
Current: $2.84
Upside: +41.09%
Feb 2, 2026
Downgraded: Sell
Price Target: $0.43
Current: $0.12
Upside: +258.33%
Sep 2, 2024
Reiterated: Buy
Price Target: $0.58 → $0.24
Current: $0.00
Upside: n/a
Sep 1, 2022
Reiterated: Buy
Price Target: $0.22 → $0.29
Current: $0.02
Upside: n/a
Mar 9, 2022
Downgraded: Sell
Price Target: $1.28 → $0.78
Current: $0.25
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $1.43
Current: $0.09
Upside: n/a
Feb 24, 2022
Reiterated: Buy
Price Target: $1.31 → $1.24
Current: $0.32
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $1.89 → $1.64
Current: $0.01
Upside: n/a